0 Comentários
0 Compartilhamentos
646 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Cardiovascular Drugs Market Analysis: Trends, Drivers, and Growth OpportunitiesThe global Cardiovascular Drugs Market is expanding with the growing burden of cardiovascular diseases, including hypertension, coronary artery disease, and heart failure. Increasing demand for effective disease management, advances in pharmaceutical research, and the development of targeted therapies are supporting market growth. Rising awareness of cardiovascular health and greater emphasis...0 Comentários 0 Compartilhamentos 217 Visualizações 0 Anterior
-
Antihypertensive Drugs Market Expanding with Rising Hypertension PrevalenceAccording to a new report from Intel Market Research, the global Antihypertensive Drugs market was valued at USD 31.96 billion in 2024 and is projected to grow from USD 33.12 billion in 2025 to reach USD 40.62 billion by 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034). This steady growth trajectory is underpinned by the escalating global burden of hypertension,...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Colestipol Market Forecast to Grow at a 2.76% CAGR Through 2034The Colestipol market faces challenges associated with tolerability and the practical demands of long-term therapy. Patient counseling about administration, possible gastrointestinal effects, and potential interactions with other medicines can help clinicians manage treatment effectively. The global Colestipol Market was valued at US$ 158.52 million in 2025 and is expected to reach US$ 202.46...0 Comentários 0 Compartilhamentos 379 Visualizações 0 Anterior
-
Dobutamine Market Growing at 5.8% CAGR Through 2034According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
North America Bisoprolol Market Size and Forecast 2034The global cardiovascular therapeutics industry is witnessing substantial growth due to the increasing prevalence of hypertension, heart failure, and other cardiac disorders worldwide. Bisoprolol, a widely prescribed beta-blocker medication, plays a crucial role in managing cardiovascular conditions by regulating heart rate and reducing blood pressure. Growing awareness regarding heart health,...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Unfractionated Heparin Market Segmentation Analysis by Dosage Form and End UserThe global unfractionated heparin market continues to play a vital role in the healthcare industry due to the widespread use of anticoagulants in preventing and treating thromboembolic disorders. Unfractionated heparin (UFH) remains one of the most commonly used anticoagulant therapies in hospitals and clinical settings because of its rapid onset of action, established safety profile, and...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek